Among these, BRCA1, BRCA2, and PALB2 were still classified as high risk, and ATM, BARD1, CHEK2, and RAD51D were still classified as moderate risk breast cancer susceptibility genes in Chinese women (Supplementary Table S4). The gene discussed is BARD1; the disease is breast carcinoma.